INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
27/03/2026
Voltar para busca
Dado oficial do USPTO
SAH SWISS ALP HEALTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
53
Atualização mais recente
28/03/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
03/07/2013
Data de registro
19/08/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/01/2025
Última transação
28/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
Belmont-Lausanne, CH
Examinador
MACIOL II, EUGENE VALENTINE-JO
Localização atual
Historical data usage
Descrição da marca
The mark consists of the wording "SWISS ALP HEALTH" below a shaded circle with the letters "SAH" appearing inside with decorative hearts and scroll designs appearing around the circle.
Titulares e representantes
Titulares
S. S. (pessoa física)
R. B. (pessoa física)
Representantes
James R Menker Holley & Menker, PA
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of disordersdiseasesconditions and ailments of the central nervous system; pharmaceutical preparations and substances for the preventiontreatment and alleviation of depression; pharmaceutical preparations and substances for the preventiontreatment and alleviation of sleep disordersstress and anxietyherbal pharmaceutical preparations; pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of disordersdiseasesconditions and ailments of the cardio-vascular system; pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of disordersdiseasesconditions and ailments of the respiratory system; pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of disordersdiseasesconditions and ailments of the immune system; pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of disordersdiseasesconditions and ailments of the musculo-skeletal systembone and connective tissue diseases and bone and cartilage degenerative conditions; Chondroitin preparations for human and veterinary use; pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of pain and inflammationsystemic and topical pain relief medication and anti-inflammatories; pharmaceutical preparations and substancesmedicated skin care preparations for use in dermatologydermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in ophthalmologyophthalmic preparations and ophthalmologic preparations; pharmaceutical preparations and substances for the preventiontreatment and alleviation of menopausecirculatoryneurologicdigestiveauto-immunepulmonarymusculoskeletalgastrointestinalskeletalviralurinaryrenalinfectiousmetabolic diseasesillnessesdisorders or conditions; sanitary preparations for medical use; dietetic food and substances for medical or veterinary usedietary and nutritional supplements in liquidpowder or solid formsamino acids for nutritional purposespowdered nutritional supplement concentratevitamin preparationsvitamin and mineral preparations for medical useherbal supplementsmedicinal herb extractsprotein supplementsnutritional supplements in the nature of carbohydrates in liquidpowder or solid formsdietary fiber to aid digestionmedicated creams and lotions for dermatological use; food for babies ; food supplements for humans and animals; medical plasters; medical dressings; herbicides; all the aforesaid goods of Swiss origin
Publicações
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
30/09/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
30/01/2025
71AG
REGISTERED-SEC.71 ACCEPTED
30/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/01/2025
ES71
TEAS SECTION 71 RECEIVED
25/07/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
19/08/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
14/07/2023
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
25/06/2021
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
25/06/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/06/2021
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
20/06/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/05/2021
INPC
INVALIDATION PROCESSED
06/05/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/05/2021
E15R
TEAS SECTION 15 RECEIVED
01/01/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/09/2020
71AG
REGISTERED-SEC.71 ACCEPTED
01/09/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31/08/2020
ES71
TEAS SECTION 71 RECEIVED
12/08/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
01/03/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/01/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/12/2014
FIMP
FINAL DISPOSITION PROCESSED
10/12/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/11/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
19/08/2014
PUBO
PUBLISHED FOR OPPOSITION
03/06/2014
GPNX
NOTIFICATION PROCESSED BY IB
30/05/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
22/05/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/05/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
14/05/2014
NPUB
NOTICE OF PUBLICATION
14/05/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
25/04/2014
ALIE
ASSIGNED TO LIE
23/04/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
13/03/2014
CNFR
FINAL REFUSAL MAILED
11/03/2014
CNFR
FINAL REFUSAL WRITTEN
10/03/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/02/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/02/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/02/2014
RFNT
REFUSAL PROCESSED BY IB
16/11/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/10/2013
RFRR
REFUSAL PROCESSED BY MPU
25/10/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/10/2013
CNRT
NON-FINAL ACTION WRITTEN
23/10/2013
DOCK
ASSIGNED TO EXAMINER
16/10/2013
MAFR
APPLICATION FILING RECEIPT MAILED
27/09/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/09/2013
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
20/09/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/09/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SAH SWISS ALP HEALTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.